Anti-phosphatidylserine/prothrombin (aPS/PT) antibodies have begun to be considered potentional biomarkers for antiphospholipid syndrome (APS). This cohort study investigate the role of aPS/PT antibodies as a risk factor for severe APS by evaluating the association between those antibodies and clinical/laboratory profiles of APS.
Antiphosphatidylserine/prothrombin antibodies as biomarkers to identify severe primary antiphospholipid syndrome
HOXHA, ARIELA;MATTIA, ELENA;TONELLO, MARTA;PENGO, VITTORIO;RUFFATTI, AMELIA
2016
Abstract
Anti-phosphatidylserine/prothrombin (aPS/PT) antibodies have begun to be considered potentional biomarkers for antiphospholipid syndrome (APS). This cohort study investigate the role of aPS/PT antibodies as a risk factor for severe APS by evaluating the association between those antibodies and clinical/laboratory profiles of APS.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
10.1515_cclm-2016-0638.pdf
accesso aperto
Tipologia:
Published (Publisher's Version of Record)
Licenza:
Accesso libero
Dimensione
292.27 kB
Formato
Adobe PDF
|
292.27 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
